Brought to you by 
LabCorp acquires Esoterix for $150mm
05 May 2005
Executive Summary
To strengthen its position as scientific leader in the lab industry, Laboratory Corp. of America Holdings (LabCorp) has acquired from private equity firm Behrman Capital all the outstanding shares of specialty diagnostics company Esoterix for $150mm in cash.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
- Laboratory Testing Services
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Hematology, Coagulation
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Intra-Biotech Deal
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
LabCorp acquires Esoterix for $150mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice